Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder

NCT03748446 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03748446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 5, 2019
Completion date
November 6, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, major depressive disorder